We have developed a new micromethod to study the effect of drugs on microsporidia, using MRC5 fibroblasts infected by 105 spores of Encephalitozoon cuniculi. After 3 days of incubation with various concentrations of drugs, parasitic foci were counted in stained cultures. The inhibition of microsporidial growth exceeding 90% with albendazole (0.005 ,ug/ml), fumagillin (0.001 ,ug/ml), 5-fluorouracil (3 ,ug/ml), and sparfloxacin (30 ,ug/ml) was observed. Chloroquine, pefloxacin, azithromycin, and rifabutin were partially effective, at high concentrations. Arprinocid, metronidazole, minocycline, doxycycline, itraconazole, and difluoromethylornithine were not evaluable, since concentrations that inhibited microsporidia were also toxic for fibroblasts. Pyrimethamine, piritrexim, sulfonamides, paromomycin, roxithromycin, atovaquone, and flucytosine were ineffective. Our results confirm that albendazole and fumagillin have marked activity against E. cuniculi and show the antimicrosporidial activity of 5-fluorouracil and sparfloxacin. These data may form the basis for treatment of Encephalitozoon hellem and Septata intestinalis infections and represent an attempt to identify drugs effective against Enterocytozoon bieneusi.
Microsporidia are emerging as opportunistic pathogens in immunocompromised patients, especially those with AIDS (7, 27) . Although there have been major advances in curative treatment and prophylaxis of protozoan opportunistic infections, there is still no effective treatment for microsporidiosis; moreover, in vitro and in vivo experimental models for evaluating the activity of antimicrobial agents against these parasites are lacking. Enterocytozoon bieneusi, probably the most frequent microsporidian infecting AIDS patients, cannot be continuously cultured and does not infect laboratory animals. Other major species infecting AIDS patients are Encephalitozoon hellem (11) , Septata intestinalis (3), and Encephalitozoon cuniculi (32, 38) , which belong or are closely related to the getius Encephalitozoon. The conditions for tissue culture and maintenance of E. cuniculi in vitro are well established, and the effects of antimicrobial agents and disinfectants against this parasite have been evaluated previously (6, 28, 29, 35) . Albendazole, fumagillin, and to a lesser degree chloroquine were found to inhibit microsporidial growth, as assessed by a reduction in the number of infected cells or excreted spores. However, the relationship between the inhibitory effect and the concentration of the antimicrobial agent was not precisely determined, since only one or two concentrations of each drug were tested. The objective of our study was to develop a microculture method suitable for screening drugs and for characterizing their inhibitory effect on microsporidia. We first compared the growth kinetics of E. cuniculi in MDCK and MRC5 cells cultured in 24-and 96-well tissue culture plates and defined the optimum conditions for large-scale drug testing, in terms of feasibility and reproducibility. We then used this micromethod to study the activities of 22 drugs, selected on the basis of their activity against protozoa and intracellular microorganisms.
MATERIALS AND METHODS
Strains of E. cuniculi. We obtained stock cultures of E. cuniculi in Madin-Darby canine kidney (MDCK) cells from E. Canning (Department of Protozoology, Imperial College, Ascot, United Kingdom). Cultures were fed with minimum essential medium (Eurobio, Paris, France) supplemented with glutamine (290 ,ug/ml), penicillin (100 IU/ml), streptomycin (50 ,ug/ml), and 1% heat-inactivated fetal calf serum (Flow Laboratories, Paris, France) and maintained in 75-cm2 flasks at 37°C in humidified 5% C02-95% air. The culture medium was changed weekly. Under these culture conditions, the rate of destruction of infected cells by E. cuniculi paralleled the rate of growth of uninfected MDCK cells and the infected cultures could be maintained almost indefinitely. Spores were harvested weekly from the supernatant by centrifugation at 3000 x g and were then used to inoculate fresh cell cultures and for strain maintenance. About 108 spores were collected from each flask after six weeks of infection.
Preparation Assessment of the effects of antimicrobial agents. Cultures were examined daily, and the presence of a cytopathic effect and the aspect of parasitized cells were recorded. At day 3 postinoculation, the cultures were fixed and stained with eosin-methylene blue as described above and parasite foci were counted under an inverted microscope at a magnification of x200. Because of the limits of magnification of the inverted microscope, only infected cells containing parasitic foci measuring at least 5 ,um across could be identified. In each replicate well, parasitic foci were counted microscopically in the whole-cell culture and the mean ± standard error (SE) of the numbers of parasitic foci per well was calculated. The percent inhibition of microsporidial growth was calculated as follows: [1 - (mean number of parasitic foci with the drug/ mean number of parasitic foci in controls)] x 100.
Differences between the counts in treated and control wells were analyzed by using the nonparametric Mann-Whitney test and were considered significant if the P value was 0.05 or less.
In a first set of experiments, each drug was examined at three different concentrations; if an inhibitory effect was noted at one of these concentrations, the drug was retested over a wider range of concentrations. Finally, to examine the cytopathic effect of the drug on the parasites, the bottom of the 96-well plate was stamped out and mounted on a microscope slide for examination at a magnification of x 1,000.
Assessment of the cellular toxicities of antimicrobial agents.
The potential toxic effects of the drugs and solvents on the cultures were examined in a separate experiment. Each dilution of each drug and solvent was added to uninfected MRC5 cell cultures prepared in 96-well plates, as described above, and then cultures were incubated for 3 days at 37°C. Monolayers were examined with an inverted microscope for the presence of a cytopathic effect, and then the stained cultures were examined for cellular alterations. A separate plate was used to test for viability, on the basis of the reduction by living cells of tetrazolium salt to a blue formazan product (8, 26) . the monolayer and were difficult to count. In MRC5 cell cultures, parasitic foci were first observed on day 3 postinfection and were more readily identified, since these fibroblasts form a thin and continuous monolayer; microscopic examination was not hampered by uninfected or detached cells. The number of parasitic foci was directly related to the size of the inoculum, and infection with 105 spores per well was found to be optimum for direct counting of parasitic foci, on day 3 or 4 postinfection. On day 3, the mean number of parasitic foci per well, calculated in three separate experiments (12 plates, with 144 replicate wells) was 585.5 ± 144; in each experiment, the mean intraplate variability between wells was 9.7% ± 3.3%.
Examination of parasites in cultures on coverslips was also simpler in MRC5 than in MDCK cell cultures, and E. cuniculi grew more rapidly in MRC5 than in MDCK cells ( Fig. 1 and 2B and C). At the early stage of infection, the cytoplasm of infected MRC5 cells contained one or two parasitic vacuoles located in a juxtanuclear position and enclosing two or three elongated, often binucleate elements which lay along the vacuole membrane. As infection progressed, the number of elements increased and completely filled the vacuole, which enlarged and progressively invaded the entire cytoplasm of the parasitized cell. On day 3 postinfection, spores were identified in the vacuole by their blue cytoplasm and red nuclei ( Fig. 2A  and B) .
Eflects of antimicrobial agents. Results obtained with each antimicrobial agent, tested at three concentrations, are shown in Table 1 : the percent growth inhibition relative to that of the untreated controls is presented with the results of the colorimetric assay of viability of uninfected cells. Fig. 3 to 6 show the results obtained with a wider range of drug concentrations which were inhibitory for microsporidia but nontoxic for fibroblasts. No cellular toxicity was recorded with dimethylsulfoxide, 0.1 M NaOH, or the acetone-methanol mixture for concentrations in the cultures up to 2, 5, and 5%, respectively, i.e., concentrations which are higher than those in the drug test wells. Four drugs were remarkably inhibitory: fumagillin, albendazole, 5-fluorouracil, and sparfloxacin. With fumagillin, a significant inhibitory effect was observed at concentrations of 20.0005 jig/ml, with 100% inhibition at 0.01 jig/ml (Fig. 3) .
Microscopic examination (magnification, X1,000) of stained cultures incubated with fumagillin at 0.01 and 0.05 jig/ml showed distorted organisms enclosed in a small vacuole; no parasites were seen at higher concentrations. With albendazole, a marked inhibitory effect was observed at 0.005 ,ug/ml (P < 0.001) and there was complete inhibition at 0.01 ,ug/ml (Fig.  4) . Microscopic examination (magnification, X1,000) showed small vacuoles enclosing one to three enlarged sausage-shaped organisms that each contained blue cytoplasm and a large purple nucleus (Fig. 2D) . Concentrations of over 0.2 jig/ml were toxic for uninfected cells. 5-Fluorouracil exhibited a significant inhibitory effect at 1 jig/ml (P = 0.004), which gradually increased to 100% inhibition at concentrations of .10 ,ug/ml (Fig. 5) . At concentrations that were not completely inhibitory, microscopic examination at a magnification of x 1,000 showed both small vacuoles enclosing amorphous material (possibly degenerated parasites) and tiny, apparently normal parasitic foci; the number and size of these foci decreased as the drug concentration increased. Sparfloxacin was effective at 20 jig/ml (P < 0.001) and completely inhibited growth at 30 and 50 ,ug/ml (Fig. 6) . Microscopically (magnification, x 1,000), observations were the same as with 5-fluorouracil.
Four drugs exhibited an incomplete but significant inhibitory effect. Pefloxacin was tested at seven concentrations (0.5 to 30 jig/ml). An inhibition of 35% (P < 0.001) was observed at 20 ,ug/ml, but at 30 ,ug/ml fibroblast morphology was markedly altered (even though viability decreased only slightly in the colorimetric assay) and it was not possible to count the parasites. With azithromycin, a partial (28%) but significant inhibition of parasite growth was observed at 100 ,ug/ml (P = 0.006). Stronger inhibition was obtained at 200 ,ug/ml, but this was associated with significant toxicity for fibroblasts, evidenced by both microscopic examination and the colorimetric assay. A slight but significant inhibitory effect (12%) was noted with rifabutin at 10 ,ug/ml (P = 0.01); the inhibitory effect increased to 22% at 20 ,ug/ml (P < 0.001), but this concentration was partially toxic for fibroblasts. Chloroquine was tested at five concentrations, ranging from 0.2 to 25 jig/ml. It was effective at 10 (29% inhibition; P = 0.002) and 25 (34% inhibition; P < 0.001) ,ug/ml, but the latter concentration was partially toxic for the monolayers (P = 0.004). Higher concentrations had a marked toxicity for uninfected cells. With all these drugs which were only partially effective against microsporidia, the inhibitory effect was evidenced by a reduction in the size and number of parasitic foci relative to those of untreated controls, but no morphological alterations of the parasites were noted.
Six drugs had a significant inhibitory effect on microsporidia, with a decreased number and size of parasitic foci, but only at concentrations that were toxic for the cell monolayers. Arprinocid was tested at eight concentrations ranging from 0.5 to 15 ,ig/ml. A moderate inhibition of E. cuniculi growth (20%) was observed only at 15 ,ug/ml, which was also a concentration toxic for the cell monolayer. Metronidazole was inactive at 2 and 10 ,ug/ml. A strong and significant inhibitory effect (89%) was obtained at 50 ,ug/ml, which was also highly toxic for uninfected cells. Minocycline was inactive and nontoxic at 5 ,ug/ml but highly inhibitory and toxic at 20 ,g/ml; similarly, itraconazole was inactive and nontoxic at 0.05 and 0.2 ,ug/ml and inhibitory but toxic at concentrations of .1 jig/ml. Doxycycline and DFMO had a partial inhibitory effect, but both drugs were toxic for the cell monolayers at all the concentrations tested; both the inhibitory effects and the toxicity were dose dependent. Eight other drugs were ineffective at the concentrations shown in Table 1 : atovaquone, the dihydrofolate inhibitors (pyrimethamine and piritrexim), the sulfonamides (sulfadiazine and sulfaguanidine), paromomycin, flucytosine, and roxithromycin. The numbers and sizes of parasitic foci were identical to those of control cultures at all the concentrations tested, and no morphological alterations of the parasites were noted. Sulfadiazine and roxithromycin exhibited no toxicity or efficacy at any concentration. Significant toxicity for fibroblasts was observed at concentrations of 5 ,ug/ml with atovaquone, .10 ,ug/ml with piritrexim, .20 ,ug/ml with pyrimethamine, and 2500 ,ug/ml with paromomycin and at all concentrations with flucytosine and sulfaguanidine; however, in spite of the significant toxicity on the fibroblasts, parasite growth was apparently normal.
DISCUSSION
We developed a new in vitro culture system for E. cuniculi, to examine the antimicrosporidial activity of antimicrobial agents selected for their known inhibitory effect on other protozoa. Antifungal drugs and antibiotics with activity against intracellular bacteria were also tested. The optimum condi-.2< (31) . The mode of action of fluoroquinolones against microsporidia is unknown, but they might act as on bacteria, i.e., by an interaction with DNA gyrase, thereby inhibiting DNA replication. Azithromycin and rifabutin also had an inhibitory effect on parasite growth, but at high concentrations that cannot be achieved in serum or tissues.
Several drugs were not evaluable in our system since their inhibitory effect on microsporidia corresponded to a toxic effect on uninfected cell monolayers. In particular, it was not possible to evaluate the effect of itraconazole, which is inhibitory for Nosema apis in vitro (23) , inhibits polar filament extrusion of E. hellem (22) , and is partially effective in the treatment of keratoconjunctivitis due to E. hellem (37 (20) . Several cases of infection by E. cuniculi have been reported in humans, but this parasite most commonly infects other animals (30) . In immunocompromised patients, particularly those with AIDS, the main infecting species are E. bieneusi, E. hellem, and the new species S. intestinalis (7) . There are major antigenic similarities and DNA sequence homologies between E. hellem and E. cuniculi (34, 39) , and these two species are morphologically indistinguishable (12); less is known of S. intestinalis, but this parasite, like E. cuniculi and E. hellem, can infect macrophages and multiply within a parasitophorous vacuole. Given these similarities and the absence of in vitro models for culture of other human microsporidia, we consider that the results obtained with E. cuniculi represent a reasonable experimental basis for therapeutic trials in patients infected by E. hellem or S. intestinalis. This hypothesis is also supported by the fact that albendazole and fumagillin, which are both highly inhibitory for E. cuniculi in vitro, are effective in the treatment of human E. hellem and S. intestinalis infections (1, 13, 21) . The relevance of our results to the treatment of E. bieneusi infections may be more limited, despite the fact that recent clinical data suggest that albendazole is also partially effective against E. bieneusi infection in AIDS patients (14) . The sites of E. cuniculi and E. bieneusi infections are different, although a gastrointestinal portal of entry is likely for both species (27, 36) . Their intracellular biologies differ markedly: E. bieneusi does not multiply within a parasitophorous vacuole (4) , and this may modify the pharmacokinetics and modes of action of drugs that we found effective against E. cuniculi. However, in the absence of other experimental models of E. bieneusi infection, the results we report here should form a basis for clinical trials pending successful in vitro culture of E. bieneusi.
